Does the media refer more to CV or OM?

In the previous week, CapsoVision and CapsoVision both had 2 articles in the media. Outset Medical's average media sentiment score of 0.94 beat CapsoVision's score of 0.93 indicating that Outset Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CapsoVision 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Outset Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, OM or CNXU?

Conexeu Sciences has lower revenue, but higher earnings than Outset Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Outset Medical $119.48M 0.68 -$81.65M -$4.16 N/A Conexeu Sciences N/A N/A N/A N/A N/A

Does the media refer more to OM or CNXU?

In the previous week, Conexeu Sciences had 5 more articles in the media than Outset Medical. MarketBeat recorded 7 mentions for Conexeu Sciences and 2 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.94 beat Conexeu Sciences' score of 0.90 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CARL or OM more profitable?

Carlsmed has a net margin of -57.76% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Carlsmed's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% Outset Medical -63.65% -56.13% -27.45%

Does the media prefer CARL or OM?

In the previous week, Carlsmed and Carlsmed both had 2 articles in the media. Carlsmed's average media sentiment score of 0.94 equaled Outset Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Outset Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Outset Medical (OM) Competitors

$4.38 -0.20 (-4.26%)

As of 02:22 PM Eastern

Compare

OM vs. CV, ELMD, SGHT, CNXU, and CARL

Should you buy Outset Medical stock or one of its competitors? MarketBeat compares Outset Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Outset Medical include CapsoVision (CV), Electromed (ELMD), Sight Sciences (SGHT), Conexeu Sciences (CNXU), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry.

How does Outset Medical compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Outset Medical (NASDAQ:OM) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

In the previous week, CapsoVision and CapsoVision both had 2 articles in the media. Outset Medical's average media sentiment score of 0.94 beat CapsoVision's score of 0.93 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CapsoVision	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CapsoVision presently has a consensus price target of $8.50, suggesting a potential upside of 14.25%. Outset Medical has a consensus price target of $10.00, suggesting a potential upside of 128.05%. Given Outset Medical's higher possible upside, analysts plainly believe Outset Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Outset Medical has a net margin of -63.65% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Outset Medical	-63.65%	-56.13%	-27.45%

CapsoVision has higher earnings, but lower revenue than Outset Medical. CapsoVision is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.56M	27.41	-$25.32M	-$2.34	N/A
Outset Medical	$119.48M	0.68	-$81.65M	-$4.16	N/A

Summary

Outset Medical beats CapsoVision on 7 of the 13 factors compared between the two stocks.

How does Outset Medical compare to Electromed?

Electromed (NYSE:ELMD) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Electromed has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.93	$5.15M	$1.17	36.51
Outset Medical	$119.48M	0.68	-$81.65M	-$4.16	N/A

In the previous week, Outset Medical had 2 more articles in the media than Electromed. MarketBeat recorded 2 mentions for Outset Medical and 0 mentions for Electromed. Outset Medical's average media sentiment score of 0.94 beat Electromed's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Electromed	Neutral
Outset Medical	Positive

40.8% of Electromed shares are held by institutional investors. 10.5% of Electromed shares are held by insiders. Comparatively, 2.5% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Electromed has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

Electromed has a net margin of 11.34% compared to Outset Medical's net margin of -63.65%. Electromed's return on equity of 15.71% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Outset Medical	-63.65%	-56.13%	-27.45%

Electromed currently has a consensus target price of $37.50, indicating a potential downside of 12.22%. Outset Medical has a consensus target price of $10.00, indicating a potential upside of 128.05%. Given Outset Medical's higher possible upside, analysts plainly believe Outset Medical is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Electromed beats Outset Medical on 11 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Sight Sciences?

Outset Medical (NASDAQ:OM) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Sight Sciences has lower revenue, but higher earnings than Outset Medical. Sight Sciences is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.68	-$81.65M	-$4.16	N/A
Sight Sciences	$77.36M	4.04	-$38.43M	-$0.71	N/A

Sight Sciences has a net margin of -46.83% compared to Outset Medical's net margin of -63.65%. Sight Sciences' return on equity of -52.34% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Sight Sciences	-46.83%	-52.34%	-28.49%

Outset Medical currently has a consensus target price of $10.00, suggesting a potential upside of 128.05%. Sight Sciences has a consensus target price of $8.14, suggesting a potential upside of 41.88%. Given Outset Medical's higher possible upside, analysts plainly believe Outset Medical is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44

55.5% of Sight Sciences shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 28.9% of Sight Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Outset Medical had 1 more articles in the media than Sight Sciences. MarketBeat recorded 2 mentions for Outset Medical and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat Outset Medical's score of 0.94 indicating that Sight Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Outset Medical	Positive
Sight Sciences	Very Positive

Outset Medical has a beta of 1.95, meaning that its stock price is 95% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.41, meaning that its stock price is 141% more volatile than the broader market.

Summary

Sight Sciences beats Outset Medical on 11 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Conexeu Sciences?

Outset Medical (NASDAQ:OM) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Conexeu Sciences has a net margin of 0.00% compared to Outset Medical's net margin of -63.65%. Conexeu Sciences' return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Conexeu Sciences	N/A	N/A	N/A

In the previous week, Conexeu Sciences had 5 more articles in the media than Outset Medical. MarketBeat recorded 7 mentions for Conexeu Sciences and 2 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.94 beat Conexeu Sciences' score of 0.90 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Conexeu Sciences has lower revenue, but higher earnings than Outset Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.68	-$81.65M	-$4.16	N/A
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Outset Medical currently has a consensus price target of $10.00, suggesting a potential upside of 128.05%. Conexeu Sciences has a consensus price target of $20.00, suggesting a potential upside of 90.95%. Given Outset Medical's higher probable upside, equities research analysts plainly believe Outset Medical is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Conexeu Sciences beats Outset Medical on 5 of the 9 factors compared between the two stocks.

How does Outset Medical compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and Outset Medical (NASDAQ:OM) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Carlsmed has a net margin of -57.76% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Outset Medical	-63.65%	-56.13%	-27.45%

In the previous week, Carlsmed and Carlsmed both had 2 articles in the media. Carlsmed's average media sentiment score of 0.94 equaled Outset Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Carlsmed currently has a consensus price target of $19.33, suggesting a potential upside of 73.08%. Outset Medical has a consensus price target of $10.00, suggesting a potential upside of 128.05%. Given Outset Medical's higher probable upside, analysts plainly believe Outset Medical is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Carlsmed has higher earnings, but lower revenue than Outset Medical. Carlsmed is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.01	-$29.63M	-$2.51	N/A
Outset Medical	$119.48M	0.68	-$81.65M	-$4.16	N/A

Summary

Outset Medical beats Carlsmed on 5 of the 9 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OM vs. The Competition

Export

Metric	Outset Medical	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$81.28M	$1.73B	$6.83B	$12.42B
Dividend Yield	N/A	N/A	2.67%	6.11%
P/E Ratio	-1.05	79.49	25.83	24.32
Price / Sales	0.68	7.26	549.34	102.14
Price / Cash	N/A	24.73	29.09	36.93
Price / Book	0.63	5.68	10.95	6.47
Net Income	-$81.65M	-$54.76M	$3.58B	$336.72M
7 Day Performance	-10.14%	5.40%	2.66%	0.67%
1 Month Performance	-10.33%	-1.91%	0.35%	-0.58%
1 Year Performance	-77.01%	2.08%	35.74%	30.43%

Outset Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OM Outset Medical	2.8963 of 5 stars	$4.39 -4.3%	$10.00 +128.1%	-76.0%	$81.28M	$119.48M	N/A	520
CV CapsoVision	0.7466 of 5 stars	$6.50 +0.3%	$8.50 +30.8%	N/A	$323.76M	$13.55M	N/A	90
ELMD Electromed	0.5766 of 5 stars	$38.53 +0.3%	$37.50 -2.7%	+88.5%	$319.03M	$71.75M	51.37	160	Positive News
SGHT Sight Sciences	3.7695 of 5 stars	$5.41 +3.2%	$8.14 +50.5%	+32.3%	$285.11M	$77.36M	N/A	210	Positive News
CNXU Conexeu Sciences	4.6567 of 5 stars	$10.55 -13.4%	$20.00 +89.6%	N/A	$282.30M	N/A	N/A	4

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OM) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Outset Medical (OM) Competitors

OM vs. CV, ELMD, SGHT, CNXU, and CARL

How does Outset Medical compare to CapsoVision?

Summary

How does Outset Medical compare to Electromed?

Summary

How does Outset Medical compare to Sight Sciences?

Summary

How does Outset Medical compare to Conexeu Sciences?

Summary

How does Outset Medical compare to Carlsmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Outset Medical (OM) Competitors

OM vs. CV, ELMD, SGHT, CNXU, and CARL

How does Outset Medical compare to CapsoVision?

Does the media refer more to CV or OM?

Do analysts rate CV or OM?

Is CV or OM more profitable?

Which has better earnings & valuation, CV or OM?

Summary

How does Outset Medical compare to Electromed?

Which has better valuation & earnings, ELMD or OM?

Does the media refer more to ELMD or OM?

Do insiders & institutionals believe in ELMD or OM?

Which has more risk and volatility, ELMD or OM?

Is ELMD or OM more profitable?

Do analysts prefer ELMD or OM?

Summary

How does Outset Medical compare to Sight Sciences?

Which has preferable valuation & earnings, OM or SGHT?

Is OM or SGHT more profitable?

Do analysts prefer OM or SGHT?

Do insiders and institutionals have more ownership in OM or SGHT?

Does the media prefer OM or SGHT?

Which has more risk & volatility, OM or SGHT?

Summary

How does Outset Medical compare to Conexeu Sciences?

Is OM or CNXU more profitable?

Does the media refer more to OM or CNXU?

Which has stronger valuation and earnings, OM or CNXU?

Do analysts prefer OM or CNXU?

Summary

How does Outset Medical compare to Carlsmed?

Is CARL or OM more profitable?

Does the media prefer CARL or OM?

Do analysts prefer CARL or OM?

Which has better earnings & valuation, CARL or OM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools